IL-12 Regulates an Endothelial Cell-Lymphocyte Network: Effect on Metalloproteinase-9 Production

作者: Stefania Mitola , Marina Strasly , Mauro Prato , Paolo Ghia , Federico Bussolino

DOI: 10.4049/JIMMUNOL.171.7.3725

关键词: Cell biologyLymphocyteInterleukin 12AngiogenesisEndotheliumEndothelial stem cellCXCL10ChemokineCytokineBiology

摘要: IL-12 is key cytokine in innate immunity and participates tumor rejection by stimulating an IFN-γ-mediated response characterized CD8+ mediated-cytotoxicity, inhibition of angiogenesis, vascular injury. We previously demonstrated that activated lymphocytes stimulated with induced angiostatic program cocultured endothelial cells. In this study, we have extended observation showing a reciprocal modulation cellular responses occurs. Actually, the presence cells enhanced inhibitory effect on metalloproteinase-9 expression PBMC as well their ability to transmigrate across extracellular matrix. triggered intracellular signaling, indicated STAT-1 activation, appeared mainly operative CD4 + challenged IL-12, but it was also initiated On other hand, reduced activity metalloproteinase-9, up-regulated tissue inhibitor metalloproteinase-1, pathway used neutralizing Abs show IFN-inducible protein 10 (CXCL10) monokine-induced IFN-γ (CXCL9) chemokines produced both are pivotal inducing these effects. Altogether results suggest existence IL-12-regulated circuit between endothelium resulting shift proteolytic homeostasis at site

参考文章(89)
Jared A. Gollob, Erin A. Murphy, Sudipta Mahajan, Claudia P. Schnipper, Jerome Ritz, David A. Frank, Altered Interleukin-12 Responsiveness in Th1 and Th2 Cells Is Associated With the Differential Activation of STAT5 and STAT1 Blood. ,vol. 91, pp. 1341- 1354 ,(1998) , 10.1182/BLOOD.V91.4.1341
R Hanemaaijer, P Koolwijk, L le Clercq, W J A de Vree, V W M van Hinsbergh, Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor α, interleukin 1 and phorbol ester Biochemical Journal. ,vol. 296, pp. 803- 809 ,(1993) , 10.1042/BJ2960803
U P Thorgeirsson, D F Alonso, D E Gomez, H Yoshiji, Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. European Journal of Cell Biology. ,vol. 74, pp. 111- 122 ,(1997)
Lei Yao, Cecilia Sgadari, Keizo Furuke, Eda T. Bloom, Julie Teruya-Feldstein, Giovanna Tosato, Contribution of Natural Killer Cells to Inhibition of Angiogenesis by Interleukin-12 Blood. ,vol. 93, pp. 1612- 1621 ,(1999) , 10.1182/BLOOD.V93.5.1612.405A13_1612_1621
W Hashimoto, K Kumagai, R Anzai, K Ogasawara, K Takeda, S Seki, M Takahashi, M Satoh, K Sugiura, Liver NK1.1+ CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis. Journal of Immunology. ,vol. 156, pp. 3366- 3373 ,(1996)
William J. LaRochelle, Michael Jeffers, William F. McDonald, Rajeev A. Chillakuru, Neill A. Giese, Nathalie A. Lokker, Carol Sullivan, Ferenc L. Boldog, Meijia Yang, Corine Vernet, Catherine E. Burgess, Elma Fernandes, Lisa L. Deegler, Beth Rittman, Juliette Shimkets, Richard A. Shimkets, Jonathan M. Rothberg, Henri S. Lichenstein, PDGF-D, a new protease-activated growth factor Nature Cell Biology. ,vol. 3, pp. 517- 521 ,(2001) , 10.1038/35074593
Ronald M. Bukowski, Charles S. Tannenbaum, James Finke, David Armstrong, Raymond Tubbs, Nancy Wicker, Thomas A. Hamilton, Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12. Journal of Immunology. ,vol. 156, pp. 693- 699 ,(1996)